Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.50 |
| ▸ | RECQL | P46063 | 1/20 | 0.50 |
| ▸ | ATM | Q13315 | 1/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.50 |
| ▸ | PPID | Q08752 | 1/20 | 0.49 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.47 |
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
| ▸ | CA1 | P00915 | 1/20 | 0.47 |
| ▸ | CA2 | P00918 | 1/20 | 0.47 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.47 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.47 |
| ▸ | HPGD | P15428 | 2/20 | 0.47 |
| ▸ | SPHK2 | Q9NRA0 | 1/20 | 0.47 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.47 |
| ▸ | TP53 | P04637 | 1/20 | 0.46 |
| ▸ | GLA | P06280 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19401273 | 1.00 | MEN1 (0.50) | MEN1KMT2ARECQLATMSMN1; SMN2 | |
| Hydrochloric Acid SCHEMBL2840965 | 0.98 | MEN1 (0.49) | MEN1KMT2ARECQLATMSMN1; SMN2 | |
| SCHEMBL1997225 | 0.90 | ALDH1A1 (0.51) | MEN1KMT2AATMSMN1; SMN2ALDH1A1 | |
| SCHEMBL3498807 | 0.86 | BCHE (0.67) | MEN1KMT2ASMN1; SMN2SPHK2SPHK1 | |
| SCHEMBL23164929 | 0.84 | ALDH1A1 (0.53) | MEN1KMT2ARECQLATMSMN1; SMN2 | |
| SCHEMBL75205 | 0.84 | PPID (0.69) | RECQLSMN1; SMN2PPIDALDH1A1MAPT | |
| SCHEMBL27530968 | 0.83 | SPHK2 (0.49) | MEN1KMT2ARECQLSMN1; SMN2PPID | |
| SCHEMBL6811685 | 0.83 | KMT2A (0.50) | MEN1KMT2AATMSMN1; SMN2ALDH1A1 | |
| SCHEMBL1279312 | 0.83 | CA1 (0.49) | MEN1KMT2ASMN1; SMN2ALDH1A1KDM4E | |
| SCHEMBL28958210 | 0.83 | KMT2A (0.50) | MEN1KMT2AATMSMN1; SMN2ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 208 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115583903-B | Method for rapidly preparing racecadotril | 湖北广辰药业有限公司 | 2024-05-28 | — | — | CN | claimed |
| CN-115583903-A | Method for rapidly preparing racecadotril | 湖北广辰药业有限公司 | 2023-01-10 | — | — | CN | claimed |
| EP-3219335-B1 | COATING COMPOSITION AND MEDICAL DEVICE | TERUMO CORP (JP) | 2018-12-19 | — | — | EP | claimed |
| EP-3219335-A1 | COATING COMPOSITION AND MEDICAL DEVICE | Terumo Kabushiki Kaisha (JP) | 2017-09-20 | — | — | EP | claimed |
| US-20170143663-A1 | COATING COMPOSITION AND MEDICAL DEVICE | TERUMO KABUSHIKI KAISHA (JP) | 2017-05-25 | — | — | US | claimed |
| EP-2813250-B1 | COATING COMPOSITION AND MEDICAL DEVICE | TERUMO CORP (JP) | 2017-05-03 | — | — | EP | claimed |
| US-9603974-B2 | Coating composition and medical device | TERUMO KABUSHIKI KAISHA (JP) | 2017-03-28 | — | — | US | claimed |
| CN-105797218-A | Coating composition and medical device | 泰尔茂株式会社 | 2016-07-27 | — | — | CN | claimed |
| CN-104203297-B | Coating composition and medical device | TERUMO CORP. (JP) | 2016-04-06 | — | — | CN | claimed |
| US-20150056265-A1 | COATING COMPOSITION AND MEDICAL DEVICE | TERUMO KABUSHIKI KAISHA (JP) | 2015-02-26 | — | — | US | claimed |
| EP-2813250-A1 | COATING COMPOSITION AND MEDICAL DEVICE | Terumo Kabushiki Kaisha (JP) | 2014-12-17 | — | — | EP | claimed |
| CN-104203297-A | Coating composition and medical device | TERUMO CORP | 2014-12-10 | — | — | CN | claimed |
| US-20260000781-A1 | FC CONJUGATES INCLUDING AN INHIBITOR OF CD73 AND USES THEREOF | CIDARA THERAPEUTICS INC (US) | 2026-01-01 | — | — | US | disclosed |
| EP-4551563-A2 | FC CONJUGATES INCLUDING AN INHIBITOR OF CD73 AND USES THEREOF | CIDARA THERAPEUTICS, INC. (US) | 2025-05-14 | — | — | EP | disclosed |
| WO-2025064869-A2 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF CANCER | CIDARA THERAPEUTICS, INC. (US) | 2025-03-27 | — | — | WO | disclosed |
| WO-2025045106-A1 | PI3Kα INHIBITOR AND USE THEREOF | 郑州同源康医药有限公司 | 2025-03-06 | — | — | WO | disclosed |
| EP-0235575-A1 | Novel phenolic thioethers as inhibitors of 5-lipoxygenase | G.D. Searle & Co. (US) | 1987-09-09 | — | — | EP | disclosed |
| US-4663319-A | LIVER DISORDERS | TANABE SEIYSKU CO., LTD. (JP) | 1987-05-05 | — | — | US | disclosed |
| EP-0205280-A2 | Tetrahydroimidazoquinazolinone cardiac stimulants | Pfizer Limited (GB) | 1986-12-17 | — | — | EP | disclosed |
| EP-0149534-A2 | Novel thioketene derivatives and process for the preparation thereof | Tanabe Seiyaku Co., Ltd. (JP) | 1985-07-24 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170143663-A1 | COATING COMPOSITION AND MEDICAL DEVICE | SLC6A19, SLC7A1, SLC38A7 | MEN1 1761/4885KMT2A 1756/4885RECQL 3358/4885 |
| US-20260000781-A1 | FC CONJUGATES INCLUDING AN INHIBITOR OF CD73 AND USES THEREOF | FCGR2A, FCGR1A, FCGR3B | MEN1 2494/4885KMT2A 1971/4885RECQL 2204/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.